NewSquare Capital’s Celgene Corp CELG Stock Holding History

NewSquare Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-337	Closed	-$35K	–	499
2016 Q3	$35K	Buy	337 +51	+18%	+$5.52K	0.01%	172
2016 Q2	$28K	Sell	286 -22	-7%	-$2.28K	0.01%	192
2016 Q1	$31K	Buy	308 +170	+123%	+$17.5K	0.01%	190
2015 Q4	$17K	Hold	138	–	–	﹤0.01%	211
2015 Q3	$15K	Hold	138	–	–	﹤0.01%	208
2015 Q2	$16K	Hold	138	–	–	﹤0.01%	222
2015 Q1	$16K	Hold	138	–	–	﹤0.01%	210
2014 Q4	$15K	Hold	138	–	–	0.01%	224
2014 Q3	$13K	Hold	138	–	–	﹤0.01%	236
2014 Q2	$12K	Buy	138 +38	+38%	+$2.89K	﹤0.01%	214
2014 Q1	$7K	Hold	100	–	–	﹤0.01%	217
2013 Q4	$8K	Hold	100	–	–	﹤0.01%	199
2013 Q3	$8K	Buy	+100	New	+$7.01K	﹤0.01%	178

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NewSquare Capital's CELG Position: Q4 2016 in Review

NewSquare Capital sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 337 shares — an estimated $35K sold.

NewSquare Capital first reported a position in CELG in Q3 2013 and held it in 13 quarters. The position peaked at $35K in Q3 2016. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

NewSquare Capital reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
NewSquare Capital sold 337 Celgene Corp shares in Q4 2016, an estimated $35K.
NewSquare Capital first reported a position in Celgene Corp in Q3 2013 and held it in 13 quarters.
NewSquare Capital's Celgene Corp position peaked at $35K in Q3 2016.
1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on NewSquare Capital's 13F filing for Q4 2016, filed 1 Feb 2017.